Resources

Blog: Read the latest post

VibeCast: Expert interviews

 

VibeCast is our informational podcast and content series exploring the hottest topics in drug development.

Guests include biotech founders, regulatory experts, drug development executives, patient community advocates, and many other Vibe Bio community members seeking to accelerate the development of breakthrough treatments.

Additional resources

Artificial Intelligence (AI) is a broad umbrella of technologies, covering a huge swathe of algorithmic applications.
In the pharmaceutical industry, pipeline analysis plays a vital role in managing and optimizing the drug portfolio. The goal is to provide comprehensive insights into the lifecycle of drug candidates, from discovery through clinical trials to market launch.
As we move through 2024, I’m thrilled with the extraordinary work our team is doing to change how we finance drug development: from funding next-generation therapies to helping others identify the highest potential cures in their development pipelines.

In this episode, VibeCast host Ray Dogum speaks with Alex Zhavoronkov, PhD, founder and CEO of Insilico Medicine, about his journey starting the company in 2014. Insilico Medicine’s mission is to extend healthy productive longevity by transforming drug discovery and development with generative artificial intelligence. Aging research and drug development

The pursuit of novel cures in the pharmaceutical industry has always been a challenging endeavor. However, within the last decade or so, the landscape has become even more complex and disruptive due to several key factors. In this blog, we explore four major disruptions impacting the hunt for new cures

“In this episode, Alok shares his personal story of how medical conditions in his family led to the creation of Vibe Bio, and how the company aims to identify diseases with unmet needs, leveraging AI to find medicines with the highest chances of providing cures.”

Uncover new possibilities with VibeOne

Learn how VibeOne can help you discover your next indication or identify high potential development opportunities in your portfolio.